A pilot program launched by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) will help researchers probe whether existing pharmaceutical candidate drugs can be repurposed (http://1.usa.gov/1962Sm5).
It takes on average 13 years to take a candidate drug from discovery to approval, and 95% of compounds fail somewhere along the way, according to NCATS. Drug companies have large portfolios of drug compounds that have made it through various stages of development and may have some safety data available. The pilot program aims to see if some of these compounds might find new uses for diseases other than those they were initially intended to treat.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.